ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
INNATE PHARMA: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
-1.828M{"amount": -1828000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Entity
- INNATE PHARMA
- Metric
- cashflow_financing
- Period
- 2022-01-01 – 2022-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:9695002Y8420ZB8HJE29:2023-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T00:10:15.202100+02:00
Raw response SHA-256
8cc6e40d8d62bf3f280603498c300fb9…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.